home / stock / srdx / srdx news


SRDX News and Press, Surmodics Inc. From 04/11/23

Stock Information

Company Name: Surmodics Inc.
Stock Symbol: SRDX
Market: NASDAQ
Website: surmodics.com

Menu

SRDX SRDX Quote SRDX Short SRDX News SRDX Articles SRDX Message Board
Get SRDX Alerts

News, Short Squeeze, Breakout and More Instantly...

SRDX - Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference, which is being held from April 17-20, 2023. Management w...

SRDX - ADMA, AMTX and SGH are among after hour movers

2023-04-06 17:02:48 ET Gainers: Ramaco Resources ( METC ) +5% . Aemetis ( AMTX ) +5% . El Pollo Loco Holdings ( LOCO ) +5% . Independent Bank Corporation ( IBCP ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: Nurix Th...

SRDX - Surmodics ($SRDX) Trading Report

2023-03-31 13:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRDX - Surmodics stock surges 10% on FDA feedback for drug-coated balloon filing

2023-03-28 12:23:16 ET Surmodics ( NASDAQ: SRDX ) stock rose ~10% on Tuesday after the company said it received positive feedback from the U.S. Food and Drug Administration (FDA) for its proposed approach to submit an amended premarket approval (PMA) application for the SurV...

SRDX - Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil(TM) Drug-Coated Balloon

Announces Receipt of Positive Formal FDA Feedback via the Q-Submission Program Substantially reduces the anticipated time and cost needed to receive a PMA Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health car...

SRDX - When Surmodics ($SRDX) Moves Investors should Listen

2023-03-21 22:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRDX - Trading Surmodics $SRDX With Integrated Risk Controls

2023-03-12 07:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRDX - Surmodics to Participate in Upcoming Investor Conferences in March

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences: The 33rd Oppenheimer Annual Healthcare Conference , which ...

SRDX - Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , March 3, 2023 /PRNewswire/...

SRDX - Surmodics downgraded at Needham on uncertainty over drug-coated balloon

Surmodics, Inc. ( NASDAQ: SRDX ) lost sharply on Monday after Needham downgraded the medical device maker to Hold from Buy, citing uncertain prospects for the company’s investigational drug-coated balloon SurVeil. In January, Surmodics ( SRDX ) announced a reduction of 13% ...

Previous 10 Next 10